Health
COVID-19 drug remdesivir has been a big win for Gilead — and it got a boost from taxpayers – San Francisco Chronicle
With U.S. cases skyrocketing, demand for the Foster City company’s antiviral drug is only growing. Biden appointees have proposed potential legal tactics to tamp…
It was the end of April — just as the U.S. confirmed its millionth COVID-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly significant” news about a drug called remdesivir.
That was surprising because the antiviral drug, owned by Gilead Sciences and developed with investment from the federal government, had languished for years with no apparent commercial use. It had struck out as a treatment for hepatitis C and Ebola.
But early in 2020, when the first global…
-
General14 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News20 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General15 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Noosa News11 hours agoSerious traffic crash, Noosa – Sunshine Coast